Top Links

Articles Related to ERK

Erythematous, Hyperkeratotic Papule on the Left Distal Dorsal Aspect of the Middle Finger

Dermatofibroma (DF) is a common benign fibrosing lesion that can be found on any surface of the body, most often in the lower extremities. Dermatofibroma that arises on the digits, as in our present case, may be confused with other clinical entities or even malignant tumors, leading to unnecessarily aggressive treatment. To ensure proper diagnosis and treatment, dermatofibroma should be considered in the differential diagnosis of digital papules.
View complete article: PDF  |  Full-text

A Randomized Double-Blind Placebo Controlled Clinical Trial Evaluating the Effects of an Investigational Study Product on Exercise Induced Muscle Soreness, Markers of Inflammation, Muscle Damage and Exercise Performance in Healthy Males

Gherkin, a pure botanical extract from cucumber is a phytonutrient rich vegetable which may have been shown to have anti-inflammatory and pain relieving properties. The purpose of this randomized double-blind placebo study was to determine the effects of Gherkin (Cuvitus™, Actido®)on exercise performance, markers of inflammation and acute muscle soreness in healthy males.
View complete article: PDF  |  Full-text

Subacute Facial Nerve Paralysis Following Cyberknife Treatment for Vestibular Schwannoma

Facial nerve paralysis may occur along the natural progression of an untreated vestibular schwannoma, as a surgical complication following vestibular schwannoma resection, or as a late sequela of stereotactic radiation. However, facial paralysis occurring as a subacute complication of CyberKnife (Accuray, Inc., Sunnyvale, CA, USA) stereotactic radiation has not previously been reported. A 47-year-old male presented with a right vestibular schwannoma measuring 3.1 cm in greatest dimension with House-Brackmann grade I/VI facial function and American Academy of Otolaryngology – Head and Neck Surgery class a hearing. After deferring surgery, he elected to undergo CyberKnife stereotactic radiation to a total dose of 18 Gy in three stages.
View complete article: PDF  |  Full-text

Hyperkinetic Manifestation in a Patient with Hippocampal Atrophy

Describes a case of a patient that presents with hippocampal atrophy leading to hyperkinetic crises of parietal-occipital origin
View complete article: PDF  |  Full-text

IL-8 Regulates Epithelial-Mesenchymal Transition through pERK1/2 in AGS Cells

The aim of this project was to evaluate the influence of inflammatory cytokines IL-1β and IL-8 on gastric epithelial-mesenchymal transition in gastric epithelial cells.
View complete article: PDF  |  Full-text

Tolerating Extreme Hyperkalemia in a Non-Compliant Dialysis Patient

Dialysis patients are known to tolerate high potassium due to the chronic hyperkalemia that is inherent in their disease. Despite this, most reports of extremely high potassium (>9 mmol/L) are in the setting of cardiac arrest. We describe the case of a 57-year-old Caucasian male with past medical history significant for end stage renal disease known to be non-adherent to a low potassium diet as well as missed dialysis appointments.
View complete article: PDF  |  Full-text

Mckittrick-Wheelock Syndrome and Diabetes Insipidus

Secretory villous adenoma is characterized with watery diarrhea, which may lead to dehydration, with resulting volume depletion, electrolyte imbalance, circulatory failure and renal dysfunction. We hereby report a case of villous adenoma associated with severe electrolyte imbalance complicated by diabetes insipidus.
View complete article: PDF  |  Full-text

A New Bi-Functional Derivative of Polyethylene Glycol as Molecular Carrier for Eugenol and Ibuprofen

Eugenol (EU) and ibuprofene (IBU) were covalently bound to a bi-functionalized PEG, used as molecular carrier of drugs and the release kinetics of the two bioactive molecules was studied in vitro in buffer solution at pH 7.4, in simulated gastric fluid and in mouse plasma.
View complete article: PDF  |  Full-text

Drug Tolerability and Outcomes in Kidney Transplant Recipients Treated with Two Formulations of Mycophenolic Acid

Mycophenolic Acid (MPA) is one of the most widely used immunosuppressive agents in kidney transplantation. This study was designed to compare the safety, tolerability and efficacy of two formulations of mycophenolic acid, Mycophenolate Mofetil (MMF) and Enteric-Coated Mycophenolate Sodium (EC-MPS), in renal transplant recipients.
View complete article: PDF  |  Full-text  | Digital
 
 


Editorial Board Members Related to ERK

Aladin M Boriek

Professor
Department of Medicine
Baylor College of Medicine
United States

J Vernon Odom

Professor
Department of Ophthalmology
West Virginia University
United States

PATRICIA L. DALBY

Associate Professor
Department of Anesthesiology
University of Pittsburgh
United States

ROSE BERKUN

Assistant Professor
Department of Anesthesiology
State University of New York at Buffalo
United States

VEENA N. RAO

Professor
Department of Obstetrics and Gynecology
Morehouse School of Medicine
Georgia Cancer Center for excellence
United States

Osman Erkmen

Professor
Department of Food Engineering
University of Gaziantep
Turkey

LAUREN BERKOW

Associate Professor
Division of Neuroanesthesia
Department of Anesthesiology and Critical Care Medicine
Johns Hopkins University
United States

Hui-Fen Wu

Professor
Departmant of chemistry
National Sun Yat-Sen University
Taiwan

Özüm Erkin

Research Assistant
Public Health Nursing Department
Ege University Faculty of Nursing
Turkey

Lotfi A. Zadeh

Professor Emeritus
Department of Electrical Engineering and Computer Science
University of California
United States
Submit Manuscript